Alzheon

boxing punch blow hit punching bag fight
Biotech

Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout

Sixteen years after tramiprosate flunked a phase 3 trial, Alzheon’s prodrug form of the molecule has joined the lengthy list of Alzheimer’s failures.
Nick Paul Taylor Apr 10, 2025 8:48am
Alzheimers dementia brain memory loss

Alzheon's Alzheimer's asset axes brain injury biomarker in trial

Sep 20, 2022 6:55am
Parachute

Pfizer taps former CVS exec Denton for CFO role—Chutes & Ladders

Apr 15, 2022 9:30am
Cash

'Big hole' no more as Aduhelm opens AD drug funding 'floodgates'

Jun 10, 2021 11:03am
NIH

No IPO? No problem: Alzheon bags $47M for Alzheimer's trial

Aug 20, 2020 12:01am
Brain

It's a case of déjà vu as Alzheon pulls IPO again

Jan 17, 2019 9:55am